Company intelligence / Profile preview

PD Theranostics

Boston, Massachusetts, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

PD Theranostics developed and validated AI-guided diagnostic algorithms leveraging multi-parameter imaging and omics data for disease classification, with promising results particularly in oncology and diabetic foot ulcer research; now part of Ovation, contributing real-world, population-scale data assets for research and development

Therapeutic areas: EndocrinologyNephrologyMetabolic DisordersInfectious DiseasesGastroenterologyOncologyNeurology
Modalities: advanced imaging-based diagnostic and data platformmulti-omicsAI-driven analytics
Industry: Digital Health Medical Devices

Partnerships

Massachusetts General Hospital (Vaccine and Immunotherapy Center, PDTx platform intellectual property)Laidlaw Venture Partners (venture arm backing PDTx)

Beyond the preview

Go deeper on PD Theranostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PD Theranostics.

Explore the full profile